Carboxymethylcellulose Sodium is a macromolecular polymer excipient used in pharmaceutical formulation as a binder, coating agent, matrix former, or drug delivery component, with functional properties governed by molecular weight distribution, degree of substitution, and backbone chemistry. Toxicological assessment addresses both the intact polymer—generally of low systemic bioavailability due to molecular size—and process-related residual monomers or initiators that may possess independent toxicological significance. OEB assignment for Carboxymethylcellulose Sodium reflects the inhalable dust fraction hazard during powder processing operations and the toxicological profile of any absorbed low-molecular-weight species.
The Acceptable Daily Exposure (ADE) for Carboxymethylcellulose Sodium is derived using methodology consistent with the ISPE Risk-Based Manufacture guide, providing an internally consistent health-based limit applicable across the complete pharmaceutical product lifecycle from API synthesis through to patient administration.
